Casas, A.I.* ; Kleikers, P.W.M.* ; Geuss, E.* ; Langhauser, F.* ; Adler, T. ; Busch, D.H.* ; Gailus-Durner, V. ; Hrabě de Angelis, M. ; Egea, J.* ; Lopez, M.G.* ; Kleinschnitz, C.* ; Schmidt, H.H.H.W.*
Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke.
J. Clin. Invest. 129, 1772-1778 (2019)
lschemic stroke is a predominant cause of disability worldwide, with thrombolytic or mechanical removal of the occlusion being the only therapeutic option. Reperfusion bears the risk of an acute deleterious calcium-dependent breakdown of the blood-brain barrier. Its mechanism, however, is unknown. Here, we identified type 5 NADPH oxidase (NOX5), a calciumactivated, ROS-forming enzyme, as the missing link. Using a humanized knockin (KI) mouse model and in vitro organotypic cultures, we found that reoxygenation or calcium overload increased brain ROS levels in a NOX5-dependent manner. In vivo, postischemic ROS formation, infarct volume, and functional outcomes were worsened in NOXS-KI mice. Of clinical and therapeutic relevance, in a human blood-barrier model, pharmacological NOX inhibition also prevented acute reoxygenationinduced leakage. Our data support further evaluation of poststroke recanalization in the presence of NOX inhibition for limiting stroke-induced damage.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Calcium ; Hypoxia ; Neuroscience ; Pharmacology ; Therapeutics; Nadph Oxidase; Independent Predictor; Therapeutic Targets; Neuroprotection; Angiogenesis; Injury; Count
Keywords plus
Language
english
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
0021-9738
e-ISSN
1558-8238
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 129,
Issue: 4,
Pages: 1772-1778
Article Number: ,
Supplement: ,
Series
Publisher
American Society of Clinical Investigation
Publishing Place
2015 Manchester Rd, Ann Arbor, Mi 48104 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-500600-001
Grants
Copyright
Erfassungsdatum
2019-03-25